Literature DB >> 3160663

Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis.

J S Dhaliwal, F Y Liew, F E Cox.   

Abstract

BALB/c mice injected intravenously with 10(6) or higher doses of formaldehyde-fixed promastigotes (ffp) of Leishmania major developed significantly lower levels of delayed-type hypersensitivity (DTH) compared with uninjected control mice when they were subsequently immunized intradermally with ffp. The suppression of DTH was antigen specific and was also inducible with lethally irradiated promastigotes or soluble parasite antigens. The suppressive effect was adoptively transferable with splenic T cells which express the Lyt-1+2+ and L3T4+ phenotypes. These specific suppressor T cells were active against both the inductive and expressive phases of DTH. They were sensitive to 200 rads of gamma-irradiation in vitro and appeared to manifest the suppressive activity via soluble factors. In spite of this profound suppression of DTH, BALB/c mice injected intravenously with 4 X 10(7) ffp were substantially protected against a challenge infection with L. major promastigotes. The possible relationship between the suppressor T cells for DTH and prophylactic immunization against fatal cutaneous leishmanial infection in susceptible BALB/c mice is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160663      PMCID: PMC262033          DOI: 10.1128/iai.49.2.417-423.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

Review 1.  The role of antigen-specific T cell factors in the immune response.

Authors:  T Tada; K Okumura
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice.

Authors:  P M Preston; K Behbehani; D C Dumonde
Journal:  J Clin Lab Immunol       Date:  1978-11

3.  A single major pathway of T-lymphocyte interactions in antigen-specific immune suppression.

Authors:  B Benacerraf; R N Germain
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

4.  Single gene control of resistance to cutaneous leishmaniasis in mice.

Authors:  L J DeTolla; P A Scott; J P Farrell
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.

Authors:  E Handman; R Ceredig; G F Mitchell
Journal:  Aust J Exp Biol Med Sci       Date:  1979-02

6.  Antibodies to Leishmania tropica promastigotes during infection in mice of various genotypes.

Authors:  J O Olobo; E Handman; J M Curtis; G F Mitchell
Journal:  Aust J Exp Biol Med Sci       Date:  1980-12

7.  Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.

Authors:  D J Bradley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

8.  Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice.

Authors:  J G Howard; C Hale; W L Chan-Liew
Journal:  Parasite Immunol       Date:  1980       Impact factor: 2.280

9.  Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.

Authors:  J G Howard; C Hale; F Y Liew
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

10.  Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica.

Authors:  J G Howard; C Hale; F Y Liew
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  7 in total

1.  Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.

Authors:  S Mukhopadhyay; S Bhattacharyya; R Majhi; T De; K Naskar; S Majumdar; S Roy
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis.

Authors:  F Y Liew; S Millott; R Lelchuk; S Cobbold; H Waldmann
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

3.  The cellular immune response to a purified antigen from Leishmania mexicana subsp. amazonensis enhances the size of the leishmanial lesion on susceptible mice.

Authors:  M M Rodrigues; L Mendonça-Previato; R Charlab; M A Barcinski
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

4.  Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice.

Authors:  Hamid Mahmoudzadeh-Niknam; Simin Sadat Kiaei; Davood Iravani
Journal:  Korean J Parasitol       Date:  2007-06       Impact factor: 1.341

5.  Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.

Authors:  J S Dhaliwal; F Y Liew
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

6.  Comparative evaluation of two vaccine candidates against experimental leishmaniasis due to Leishmania major infection in four inbred mouse strains.

Authors:  Fouad Benhnini; Mehdi Chenik; Dhafer Laouini; Hechmi Louzir; Pierre André Cazenave; Koussay Dellagi
Journal:  Clin Vaccine Immunol       Date:  2009-09-02

7.  Identification of Leishmania genes encoding proteins containing tandemly repeating peptides.

Authors:  A E Wallis; W R McMaster
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.